W.W. Grainger
GWW
1,263.51
-12.05
-0.94%
W.W. Grainger
US · GWW
#383 by market cap
Listed 1970
1,263.51
-12.05
-0.94%
Live - 5344 symbols - heartbeat 197s ago
· 2026-10-08 07:41
Pre-market
1,263.51
0.00%
After-hours
1,263.51
0.00%
- Market cap
- 59.51B
- P/E (TTM)i
- 32.21
- P/Bi
- 14.41
- EPSi
- 35.40
- Div yieldi
- 0.73%
- 52W posi
- 70%
Reader sentiment
Are you bullish or bearish on GWW?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 13.14, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +4.51% YoY
Margins
- Gross margin
- 39.06%
- Operating margin
- 13.91%
- Net margin
- 9.51%
Key ratios & quality
- Enterprise valuei
- 61.49B
- PEG ratioi
- 9.72
- Altman Z-Scorei
- 13.14
PEG uses trailing P/E against the 3-year net income growth rate (3.31%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 11.22B | 11.49B | 11.80B | 13.02B | 15.23B | 16.48B | 17.17B | 17.94B |
| Gross profit | 4.35B | 4.40B | 4.24B | 4.72B | 5.85B | 6.50B | 6.76B | 7.01B |
| Selling & admin expenses | 3.19B | 3.14B | 3.22B | 3.17B | 3.63B | 3.93B | 4.12B | 4.51B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.16B | 1.26B | 1.02B | 1.55B | 2.22B | 2.57B | 2.64B | 2.50B |
| Pretax profit | 1.08B | 1.21B | 947.00M | 1.49B | 2.15B | 2.50B | 2.58B | 2.43B |
| Tax | 258.00M | 314.00M | 192.00M | 371.00M | 533.00M | 597.00M | 595.00M | 622.00M |
| Net profit | 823.00M | 895.00M | 755.00M | 1.11B | 1.61B | 1.90B | 1.99B | 1.81B |
| Basic EPS | 14 | 15 | 13 | 20 | 30 | 36 | 39 | 35 |
| Diluted EPS | 13.73 | 15.32 | 12.82 | 19.84 | 30.06 | 36.23 | 38.71 | 35.40 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 4.31B | 4.55B | 4.66B | 4.43B | 4.74B | 5.02B |
| Gross profit | 1.71B | 1.76B | 1.80B | 1.75B | 1.90B | 1.98B |
| Selling & admin expenses | 1.04B | 1.08B | 1.29B | 1.11B | 1.10B | 1.18B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 672.00M | 678.00M | 511.00M | 634.00M | 793.00M | 807.00M |
| Pretax profit | 657.00M | 661.00M | 492.00M | 620.00M | 775.00M | 798.00M |
| Tax | 157.00M | 153.00M | 171.00M | 141.00M | 194.00M | 198.00M |
| Net profit | 500.00M | 508.00M | 321.00M | 479.00M | 581.00M | 600.00M |
| Basic EPS | 10 | 10 | 6 | 9 | 12 | 12 |
| Diluted EPS | 9.86 | 9.97 | 6.12 | 9.44 | 11.65 | 12.01 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.56B | 3.56B | 3.92B | 4.01B | 4.98B | 5.27B | 5.74B | 5.48B |
| Cash & ST investments | 538.00M | 360.00M | 585.00M | 241.00M | 325.00M | 660.00M | 1.04B | 585.00M |
| Inventory | 1.54B | 1.66B | 1.73B | 1.87B | 2.25B | 2.27B | 2.31B | 2.39B |
| Total assets | 5.87B | 6.01B | 6.30B | 6.59B | 7.59B | 8.15B | 8.83B | 8.96B |
| Total current liabilities | 1.50B | 1.68B | 1.44B | 1.53B | 2.01B | 1.83B | 2.31B | 1.94B |
| Short-term debt | 130.00M | 301.00M | 65.00M | 66.00M | 103.00M | 105.00M | 577.00M | 199.00M |
| Long-term debt | 2.09B | 1.91B | 2.39B | 2.36B | 2.28B | 2.27B | 2.28B | 2.36B |
| Total liabilities | 3,780,000,000.00 | 3,945,000,000.00 | 4,202,000,000.00 | 4,432,000,000.00 | 4,853,000,000.00 | 4,706,000,000.00 | 5,126,000,000.00 | 4,821,000,000.00 |
| Total equity | 2.09B | 2.06B | 2.09B | 2.16B | 2.74B | 3.44B | 3.70B | 4.14B |
| Retained earnings | 7.87B | 8.41B | 8.78B | 9.50B | 10.70B | 12.16B | 13.68B | 14.96B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 5.53B | 5.65B | 5.47B | 5.48B | 5.91B | 6.00B |
| Cash & ST investments | 666.00M | 597.00M | 535.00M | 585.00M | 695.00M | 589.00M |
| Inventory | 2.31B | 2.36B | 2.28B | 2.39B | 2.39B | 2.37B |
| Total assets | 8.66B | 8.94B | 8.85B | 8.96B | 9.47B | 9.62B |
| Total current liabilities | 2.02B | 2.00B | 2.02B | 1.94B | 2.20B | 2.14B |
| Short-term debt | 81.00M | 83.00M | 78.00M | 199.00M | 73.00M | 74.00M |
| Long-term debt | 2.28B | 2.34B | 2.37B | 2.36B | 2.41B | 2.41B |
| Total liabilities | 4,811,000,000.00 | 4,854,000,000.00 | 4,887,000,000.00 | 4,821,000,000.00 | 5,130,000,000.00 | 5,105,000,000.00 |
| Total equity | 3.85B | 4.08B | 3.96B | 4.14B | 4.34B | 4.51B |
| Retained earnings | 14.06B | 14.43B | 14.62B | 14.96B | 15.41B | 15.86B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.06B | 1.04B | 1.12B | 937.00M | 1.33B | 2.03B | 2.11B | 2.02B |
| Depreciation & amortization | 257.00M | 229.00M | 182.00M | 187.00M | 205.00M | 214.00M | 237.00M | 254.00M |
| Free cash flow | 818.00M | 821.00M | 926.00M | 682.00M | 1.08B | 1.59B | 1.57B | 1.33B |
| Dividends paid | -316.00M | -328.00M | -338.00M | -357.00M | -370.00M | -392.00M | -421.00M | -467.00M |
| Stock buybacks / issuance | -425.00M | -700.00M | -601.00M | -695.00M | -603.00M | -850.00M | -1.20B | -1.05B |
| Ending cash balance | 538.00M | 360.00M | 585.00M | 241.00M | 325.00M | 660.00M | 1.04B | 585.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 646.00M | 377.00M | 597.00M | 395.00M | 739.00M | 444.00M |
| Depreciation & amortization | 61.00M | 64.00M | 65.00M | 64.00M | 62.00M | 66.00M |
| Free cash flow | 521.00M | 202.00M | 339.00M | 269.00M | 569.00M | 333.00M |
| Dividends paid | -115.00M | -110.00M | -133.00M | -109.00M | -108.00M | -145.00M |
| Stock buybacks / issuance | -281.00M | -226.00M | -291.00M | -247.00M | -237.00M | -224.00M |
| Ending cash balance | 666.00M | 597.00M | 535.00M | 585.00M | 695.00M | 589.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 42.98 | 44.97 | 37.74 | 56.35 | 71.72 | 65.85 | 58.98 | 48.10 |
| ROA %i | 13.29 | 14.30 | 11.30 | 16.19 | 21.82 | 23.25 | 22.49 | 19.18 |
| ROIC %i | 20.52 | 22.10 | 18.54 | 25.01 | 33.06 | 34.50 | 31.73 | 26.89 |
| 5-year avg ROE %i | 31.76 | 35.85 | 37.84 | 43.19 | 50.82 | 55.33 | 58.13 | 60.20 |
| EBIT margin %i | 10.42 | 11.21 | 8.82 | 12.07 | 14.70 | 15.74 | 15.50 | 14.00 |
| FCF / sales %i | 7.29 | 7.15 | 7.85 | 5.24 | 7.07 | 9.63 | 9.14 | 7.42 |
| Current ratioi | 2.37 | 2.12 | 2.72 | 2.63 | 2.48 | 2.88 | 2.49 | 2.83 |
| Quick ratioi | 1.28 | 1.06 | 1.43 | 1.31 | 1.22 | 1.56 | 1.42 | 1.50 |
| Debt / assetsi | 37.80 | 36.89 | 41.56 | 41.90 | 35.65 | 33.78 | 36.05 | 31.93 |
| LT debt / equityi | 108.80 | 103.18 | 139.55 | 143.86 | 106.64 | 84.98 | 77.61 | 71.28 |
| Interest coveragei | 13.28 | 16.30 | 11.18 | 18.07 | 24.08 | 27.88 | 34.56 | 31.00 |
| Revenue CAGR (3Y) %i | 4.01 | 4.25 | 4.21 | 5.09 | 9.86 | 11.78 | 9.65 | 5.62 |
| Net income CAGR (3Y) %i | 0.56 | 11.90 | 5.85 | 10.08 | 22.14 | 38.06 | 22.32 | 3.31 |
| FCF CAGR (3Y) %i | 7.29 | 3.52 | 4.14 | -5.88 | 9.47 | 19.65 | 32.04 | 7.31 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 57.19 | 55.30 | 48.98 | 48.10 | 48.10 | 47.92 |
| ROA %i | 22.39 | 22.23 | 19.26 | 19.18 | 19.66 | 20.16 |
| ROIC %i | 32.63 | 31.98 | 27.54 | 26.89 | 28.63 | 28.95 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 15.45 | 15.38 | 14.14 | 14.00 | 14.31 | 14.68 |
| FCF / sales %i | 8.99 | 8.10 | 6.94 | 7.42 | 7.50 | 8.01 |
| Current ratioi | 2.74 | 2.82 | 2.72 | 2.83 | 2.69 | 2.81 |
| Quick ratioi | 1.50 | 1.53 | 1.46 | 1.50 | 1.51 | 1.60 |
| Debt / assetsi | 30.94 | 30.54 | 30.74 | 31.93 | 29.36 | 29.08 |
| LT debt / equityi | 74.66 | 72.02 | 74.19 | 71.28 | 68.91 | 65.92 |
| Interest coveragei | 34.58 | 34.91 | 32.18 | 31.00 | 32.46 | 34.15 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- High-Touch Solutions North America (N.A.) is the largest reported line at 79.01% of revenue, across 2 reported segments.
- The next-largest line, Endless Assortment, is a distant second at 20.99% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
High-Touch Solutions North America (N.A.)79.01%
Endless Assortment20.99%
Quote time 2026-10-08 07:41:39 · For reference only, not investment advice and not tailored to your situation.